Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Lycopene improves the efficiency of anti-PD-1 therapy via activating IFN signaling of lung cancer cells

Fig. 2

The combined therapy of lycopene and anti-PD-1 synergistically regulates the immune system. The inflammatory factors in the spleen were detected by ELISA (a, b). The CD4+/CD8+ ratio in the spleen was measured by flow cytometry analysis (c, d). IFNγ+/CD8+T-cells infiltrated in the tumor tissues were determined by flow cytometry analysis (d). *p < 0.05 vs. control, #p < 0.05 vs. Anti-PD-1 (n = 6)

Back to article page